← Back
$HIMS All transactions

Hims & Hers Health, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

52,395

Price

$0

Filed

Sep 17

Insider

Name

Okupe Oluyemi

Title

Chief Financial Officer

CIK

0001907056

Roles

Officer

Transaction Details

Transaction Date

2025-09-15

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

104,791

Footnotes

The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. | The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. | The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.725 - $55.720. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.725 - $55.875. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. | 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

Filing Info

Accession No.

0001773751-25-000300

Form Type

4

Issuer CIK

0001773751

Okupe Oluyemi's History

Date Ticker Type Value
2026-04-20 HIMS M $28K
2026-04-20 HIMS M $81K
2026-04-20 HIMS $589K
2026-04-20 HIMS M $0
2026-04-20 HIMS M $0
2026-04-17 HIMS M $31K
2026-04-17 HIMS $501K
2026-04-17 HIMS M $0
2026-04-16 HIMS $956K
2026-04-06 HIMS M $20K

Other Insiders at HIMS (90d)

Insider Bought Sold Last
Dudum Andrew
Chief Executive Officer
2026-04-09
Boughton Soleil
Chief Legal Officer
$473K 2026-04-20
Carroll Patrick Harrison
Chief Medical Officer
2026-03-13
Autor Deborah M.
Chief Policy Officer
2026-03-13
Becklund Irene
PAO
$137K 2026-03-17
Okupe Oluyemi
Chief Financial Officer
$2.5M 2026-04-20
Chi Michael
Chief Operating Officer
$2.4M 2026-03-17
Pendarvis Christiane 2026-03-13
Elshenawy Mohamed
CTO
2026-03-11